BioPharma Services Inc.

12 articles about BioPharma Services Inc.

• Think Research Announces Approximately $12.8 Million of New BioPharma Contracts Signed During Q3 2022

  9/20/2022

  Think Research Corporation has signed multiple new contracts in the third quarter worth approximately $12.8 million.

• Diamond Therapeutics contracts BioPharma Services for Phase 1 clinical trial

  6/17/2021

  Diamond Therapeutics Inc. is pleased to announce the selection of BioPharma Services Inc. as the contract research organization (CRO) for its Phase 1 clinical trial.

• Renzo DiCarlo of BioPharma Services Inc. Presents COVID-19 Vaccine Strategies to Canadian Parliament

  4/27/2021

  Renzo DiCarlo, CEO of BioPharma Services Inc. was proud to be invited to appear as a witness before the House of Commons’ Standing Committee on International Trade, in view of its study entitled Canada’s International Trade and Investment Policy: Selected Considerations Concerning COVID-19 Vaccines . As a London School of Economics (LSE) alumnus in stakeholder theory research with 25 years of experience in Pharmace

• BioPharma Services, Inc. Relocates to Expanded Clinic Facility in St. Louis MO due to Covid-19

  6/8/2020

  BioPharma Services, Inc. (BioPharma) is excited to announce the relocation of their US based clinical facility to a new location in the greater city of St. Louis, Missouri. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200608005065/en/ BioPharma's new site in St. Louis MO The ongoing pandemic has compelled BioPharma to re-evaluate our clinical operations i

• BioPharma Services Inc. Donates its Clinical Resources and Scientific Expertise in the Pursuit of Coronavirus COVID-19 Vaccine Research

  3/2/2020

  BioPharma has today decided to donate its World Health Organization (WHO) approved facility for coronavirus COVID-19 vaccine research and treatments.

• BioPharma Services, Inc. to Be Recognized in Five Areas of Excellence for CRO Leadership by Life Science Leader

  5/22/2019

  Renzo Dicarlo, CEO will be accepting the Award from Life Science Leader at the annual CRO Leadership Awards presentation which takes place during the upcoming DIA Global Annual Meeting in San Diego.

• BioPharma Services, Inc. Receives a Stamp of Approval by the World Health Organization

  11/19/2018

  BioPharma received a status of Compliance valid through to the 1st of January 2021.

• MedReleaf and BioPharma Services Inc. Announce Strategic Alliance

  5/29/2018

  MedReleaf Corp. and BioPharma Services Inc. announced they have entered into an exclusive agreement to conduct clinical research for cannabis and cannabis derived products.

• BioPharma Services, Inc. Welcomes Abuse Liability Experts, Dr. John Oldenhof, VP of Clinical Pharmacology and Dr. Isabella Szeto, Principal Investigator to the BioPharma Team

  4/12/2018

  BioPharma Services, Inc. is honored to announce the addition of Dr. John Oldenhof, PhD, and Dr. Isabella Szeto, MD, CCFP, FCFP, CPI, to the Senior Management team here at BioPharma.

• BioPharma Services Completes Its 1st Year Of A 5 Year Phase 1 Program With The U.S. FDA

  9/25/2017

• BioPharma Services Successfully Completes 3 FDA Inspections With ZERO Form 483’s

  5/26/2017

• BioPharma Services Completes Another Successful Inspection By EMA

  5/4/2017